T Rowe Price
TROW
Market cap $25.3B

113.47 USD

-0.54

0.47%

Updated Oct 22, 10:49 AM EDT

1 day

-0.47%

5 days

3.00%

1 month

4.98%

3 months

-2.16%

6 months

1.77%

Year to date

5.15%

1 year

18.85%

5 years

4.88%

About: T. Rowe Price provides asset-management services for individual and institutional investors. It offers a broad range of no-load US and international stock, hybrid, bond, and money market funds. At the end of August 2024, the firm had $1.612 trillion in managed assets, composed of equity (51%), balanced (34%), fixed-income and money market (12%), and alternative (3%) offerings. Approximately two thirds of managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a US-based asset manager, deriving less than 10% of its AUM from overseas.

Employees: 7,929

Financials Security & Commodity Brokers, Dealers, Exchanges & Services

0

Funds holding %

of 6,740 funds

0

Analysts bullish %

of 13 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

21% more first-time investments, than exits

New positions opened: 91 | Existing positions closed: 75

14% more repeat investments, than reductions

Existing positions increased: 417 | Existing positions reduced: 365

13% more call options, than puts

Call options by funds: $259M | Put options by funds: $230M

2% more funds holding

Funds holding: 1,033 [Q1] → 1,049 (+16) [Q2]

1.58% less ownership

Funds ownership: 74.32% [Q1] → 72.74% (-1.58%) [Q2]

7% less capital invested

Capital invested by funds: $20.2B [Q1] → $18.7B (-$1.52B) [Q2]

18% less funds holding in top 10

Funds holding in top 10: 11 [Q1] → 9 (-2) [Q2]

See Fund Rankings

Research analyst outlook

13 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$99

13%

downside

Avg. target

$111

3%

downside

High target

$127

12%

upside

13 analyst ratings

0 positive

0%

9 neutral

69%

4 negative

31%

Morgan Stanley Michael Cyprys 68% 1-year accuracy 21 / 31 met price target	12%upside $127	Equal-Weight Maintained	18 Oct 2024
Barclays Benjamin Budish 87% 1-year accuracy 55 / 63 met price target	11%downside $101	Underweight Maintained	14 Oct 2024
Wells Fargo Michael Brown 90% 1-year accuracy 18 / 20 met price target	1%downside $112	Equal-Weight Maintained	9 Oct 2024
Evercore ISI Group Glenn Schorr 90% 1-year accuracy 19 / 21 met price target	4%downside $109	In-Line Maintained	4 Oct 2024
Goldman Sachs Alexander Blostein 82% 1-year accuracy 27 / 33 met price target	10%downside $102	Sell Maintained	3 Oct 2024

See Analyst Rankings

Financial journalist opinion

Based on 13 articles about TROW published over the past 30 days

Zacks Investment Research

IVZ vs. TROW: Which Stock Is the Better Value Option?

Investors with an interest in Financial - Investment Management stocks have likely encountered both Invesco (IVZ) and T. Rowe Price (TROW).

IVZ vs. TROW: Which Stock Is the Better Value Option?

Zacks Investment Research

Are You Looking for a High-Growth Dividend Stock?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does T. Rowe Price (TROW) have what it takes?

Are You Looking for a High-Growth Dividend Stock?

Zacks Investment Research

Can T. Rowe (TROW) Keep the Earnings Surprise Streak Alive?

T. Rowe (TROW) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Can T. Rowe (TROW) Keep the Earnings Surprise Streak Alive?

Zacks Investment Research

These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar

Buy 4 October Dividend Aristocrats & Watch 10

"Dividend Aristocrats... in the S&P500 Index… have raised their annual payouts every year for at least 25 consecutive years." -- Kiplinger.com/Investing. 67 Aristocrats, screened as of October 7, 2024 represented all eleven Morningstar Sectors. Broker estimated-top-ten net-gains ranged 10.5%-20.13% topped-by Franklin & Target.

Buy 4 October Dividend Aristocrats & Watch 10

8 Dividend Aristocrats For Monthly 6% Yield

Invest $100K in eight high-yield Dividend Aristocrats to generate $533 monthly income, with a 6.4% yield and 5%-6% dividend growth. These stocks offer 27% return potential over the next year and 86% over five years, and they're expected to outperform the S&P 500. Historical data shows these aristocrats outperformed the S&P by 4% annually over 26 years, with lower volatility and higher inflation-adjusted returns.

8 Dividend Aristocrats For Monthly 6% Yield

The Motley Fool

3 Top High-Yield Financial Stocks to Buy in October

If you are looking for high yields in October, check out these three out-of-favor financial stocks. You may like what you see.

3 Top High-Yield Financial Stocks to Buy in October

Zacks Investment Research

AMG vs. TROW: Which Stock Is the Better Value Option?

Investors interested in stocks from the Financial - Investment Management sector have probably already heard of Affiliated Managers Group (AMG) and T. Rowe Price (TROW).

AMG vs. TROW: Which Stock Is the Better Value Option?

OHA is Lead Lender and Lead Left Arranger for Alkegen Debt Refinancing

New York, New York, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Oak Hill Advisors (“OHA”) served as lead lender and Lead Left Arranger of a comprehensive debt refinancing solution for Alkegen, a global specialty materials platform providing high performance materials used in advanced applications. OHA is the largest lender across the new senior facility, which consists of new $1,925 million first lien term loan and notes facilities and a new $200 million first-out revolving credit facility. Proceeds will be used primarily to refinance in full Alkegen's existing first lien term loans, pay down outstanding borrowings under its revolver, extend maturities and provide liquidity runway for the company to execute on its growth and operational plans. In addition, a majority of existing holders of Alkegen's secured and unsecured notes due 2028 and 2029 exchanged their notes for new second lien notes due 2029. Alkegen is separately commencing an offer to exchange all of the remaining secured and unsecured notes for new second lien notes.

OHA is Lead Lender and Lead Left Arranger for Alkegen Debt Refinancing

T. Rowe Price: Be Patient Before Buying It

T. Rowe Price is a global asset manager with a strong franchise in retirement and target date funds, currently trading at a low valuation. Despite recent poor performance and net outflows, fund performance is improving, and a bull market is boosting assets under management. The stock offers a higher-than-average dividend yield with excellent safety, making it a long-term buy for dividend growth investors.

T. Rowe Price: Be Patient Before Buying It

See News Rankings

Charts implemented using Lightweight Charts™